The issue of racial diversity, equity and inclusion has been prominent in 2020, and many biotech and pharma CEOs have pledged to address the inequality in their organisations. In this article, published for the Timmerman Report, Liftstream CEO, Karl Simpson, explores the actions that companies, large and small, are taking to improve racial and ethnicity representation among their workforces, in clinical trials, and among their supply chains.
Read the article:
Liftstream is an executive search and leadership advisory company serving companies across the global life sciences industry.
